Tata Chemicals Limited
Tata Chemicals Limited (TATACHEM.NS) Stock Competitors & Peer Comparison
See (TATACHEM.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Chemicals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TATACHEM.NS | ₹609.10 | +0.62% | 148.6B | 91.71 | ₹6.36 | +1.89% |
| UPL.BO | ₹590.15 | -0.96% | 479.2B | 27.14 | ₹20.92 | +1.06% |
| FLUOROCHEM.NS | ₹3,134.30 | +2.16% | 332.7B | 50.62 | ₹59.82 | +0.10% |
| DEEPAKNI.BO | ₹2,436.10 | +0.33% | 332.3B | 57.46 | ₹42.40 | N/A |
| NAVINFLUOR.NS | ₹6,058.00 | +0.05% | 315.8B | 57.14 | ₹107.84 | +0.22% |
| NAVINFLUOR.BO | ₹6,058.50 | +0.05% | 315.5B | 57.14 | ₹107.75 | +0.22% |
| BAYERCROP.BO | ₹4,615.95 | +2.76% | 209.1B | 31.15 | ₹149.32 | +2.69% |
| DEEPAKNTR.BO | ₹1,338.10 | -0.59% | 175.6B | 32.89 | ₹39.14 | +0.58% |
| DEEPAKNTR.NS | ₹1,334.30 | -0.85% | 175.5B | 32.97 | ₹39.03 | +0.58% |
| TATACHEM.BO | ₹608.00 | +0.41% | 148.6B | 91.26 | ₹6.39 | +1.89% |
Stock Comparison
TATACHEM.NS vs UPL.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, UPL.BO has a market cap of 479.2B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while UPL.BO trades at ₹590.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas UPL.BO's P/E ratio is 27.14. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to UPL.BO's ROE of +0.05%. Regarding short-term risk, TATACHEM.NS is less volatile compared to UPL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check UPL.BO's competition here
TATACHEM.NS vs FLUOROCHEM.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, FLUOROCHEM.NS has a market cap of 332.7B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while FLUOROCHEM.NS trades at ₹3,134.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas FLUOROCHEM.NS's P/E ratio is 50.62. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to FLUOROCHEM.NS's ROE of +0.09%. Regarding short-term risk, TATACHEM.NS is less volatile compared to FLUOROCHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check FLUOROCHEM.NS's competition here
TATACHEM.NS vs DEEPAKNI.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, DEEPAKNI.BO has a market cap of 332.3B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while DEEPAKNI.BO trades at ₹2,436.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas DEEPAKNI.BO's P/E ratio is 57.46. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to DEEPAKNI.BO's ROE of +0.06%. Regarding short-term risk, TATACHEM.NS is more volatile compared to DEEPAKNI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check DEEPAKNI.BO's competition here
TATACHEM.NS vs NAVINFLUOR.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, NAVINFLUOR.NS has a market cap of 315.8B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while NAVINFLUOR.NS trades at ₹6,058.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas NAVINFLUOR.NS's P/E ratio is 57.14. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to NAVINFLUOR.NS's ROE of +0.19%. Regarding short-term risk, TATACHEM.NS is less volatile compared to NAVINFLUOR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check NAVINFLUOR.NS's competition here
TATACHEM.NS vs NAVINFLUOR.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, NAVINFLUOR.BO has a market cap of 315.5B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while NAVINFLUOR.BO trades at ₹6,058.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas NAVINFLUOR.BO's P/E ratio is 57.14. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to NAVINFLUOR.BO's ROE of +0.19%. Regarding short-term risk, TATACHEM.NS is less volatile compared to NAVINFLUOR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check NAVINFLUOR.BO's competition here
TATACHEM.NS vs BAYERCROP.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, BAYERCROP.BO has a market cap of 209.1B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while BAYERCROP.BO trades at ₹4,615.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas BAYERCROP.BO's P/E ratio is 31.15. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to BAYERCROP.BO's ROE of +0.23%. Regarding short-term risk, TATACHEM.NS is more volatile compared to BAYERCROP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check BAYERCROP.BO's competition here
TATACHEM.NS vs DEEPAKNTR.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, DEEPAKNTR.BO has a market cap of 175.6B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while DEEPAKNTR.BO trades at ₹1,338.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas DEEPAKNTR.BO's P/E ratio is 32.89. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to DEEPAKNTR.BO's ROE of +0.10%. Regarding short-term risk, TATACHEM.NS is less volatile compared to DEEPAKNTR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check DEEPAKNTR.BO's competition here
TATACHEM.NS vs DEEPAKNTR.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, DEEPAKNTR.NS has a market cap of 175.5B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while DEEPAKNTR.NS trades at ₹1,334.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas DEEPAKNTR.NS's P/E ratio is 32.97. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to DEEPAKNTR.NS's ROE of +0.10%. Regarding short-term risk, TATACHEM.NS is more volatile compared to DEEPAKNTR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check DEEPAKNTR.NS's competition here
TATACHEM.NS vs TATACHEM.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, TATACHEM.BO has a market cap of 148.6B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while TATACHEM.BO trades at ₹608.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas TATACHEM.BO's P/E ratio is 91.26. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to TATACHEM.BO's ROE of +0.01%. Regarding short-term risk, TATACHEM.NS is more volatile compared to TATACHEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check TATACHEM.BO's competition here
TATACHEM.NS vs SPLPETRO.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, SPLPETRO.NS has a market cap of 138.8B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while SPLPETRO.NS trades at ₹750.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas SPLPETRO.NS's P/E ratio is 51.74. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to SPLPETRO.NS's ROE of +0.12%. Regarding short-term risk, TATACHEM.NS is less volatile compared to SPLPETRO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check SPLPETRO.NS's competition here
TATACHEM.NS vs DEEPAKFERT.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, DEEPAKFERT.BO has a market cap of 114.8B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while DEEPAKFERT.BO trades at ₹972.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas DEEPAKFERT.BO's P/E ratio is 13.13. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to DEEPAKFERT.BO's ROE of +0.14%. Regarding short-term risk, TATACHEM.NS is less volatile compared to DEEPAKFERT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check DEEPAKFERT.BO's competition here
TATACHEM.NS vs DEEPAKFERT.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, DEEPAKFERT.NS has a market cap of 114.8B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while DEEPAKFERT.NS trades at ₹969.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas DEEPAKFERT.NS's P/E ratio is 13.11. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to DEEPAKFERT.NS's ROE of +0.14%. Regarding short-term risk, TATACHEM.NS is less volatile compared to DEEPAKFERT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check DEEPAKFERT.NS's competition here
TATACHEM.NS vs ACI.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, ACI.NS has a market cap of 72.5B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while ACI.NS trades at ₹588.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas ACI.NS's P/E ratio is 49.53. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to ACI.NS's ROE of +0.08%. Regarding short-term risk, TATACHEM.NS is more volatile compared to ACI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check ACI.NS's competition here
TATACHEM.NS vs ACI.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, ACI.BO has a market cap of 72.4B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while ACI.BO trades at ₹600.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas ACI.BO's P/E ratio is 49.51. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to ACI.BO's ROE of +0.08%. Regarding short-term risk, TATACHEM.NS is less volatile compared to ACI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check ACI.BO's competition here
TATACHEM.NS vs INDIAGLYCO.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, INDIAGLYCO.BO has a market cap of 56.9B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while INDIAGLYCO.BO trades at ₹882.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas INDIAGLYCO.BO's P/E ratio is 20.28. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to INDIAGLYCO.BO's ROE of +0.12%. Regarding short-term risk, TATACHEM.NS is less volatile compared to INDIAGLYCO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check INDIAGLYCO.BO's competition here
TATACHEM.NS vs INDIAGLYCO.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, INDIAGLYCO.NS has a market cap of 56.9B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while INDIAGLYCO.NS trades at ₹883.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas INDIAGLYCO.NS's P/E ratio is 19.66. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to INDIAGLYCO.NS's ROE of +0.12%. Regarding short-term risk, TATACHEM.NS is less volatile compared to INDIAGLYCO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check INDIAGLYCO.NS's competition here
TATACHEM.NS vs GNFC.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, GNFC.NS has a market cap of 53.8B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while GNFC.NS trades at ₹384.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas GNFC.NS's P/E ratio is 8.63. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to GNFC.NS's ROE of +0.07%. Regarding short-term risk, TATACHEM.NS is less volatile compared to GNFC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check GNFC.NS's competition here
TATACHEM.NS vs GNFC.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, GNFC.BO has a market cap of 53.8B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while GNFC.BO trades at ₹384.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas GNFC.BO's P/E ratio is 8.45. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to GNFC.BO's ROE of +0.07%. Regarding short-term risk, TATACHEM.NS is less volatile compared to GNFC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check GNFC.BO's competition here
TATACHEM.NS vs MFL.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, MFL.NS has a market cap of 44.1B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while MFL.NS trades at ₹1,062.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas MFL.NS's P/E ratio is 15.94. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to MFL.NS's ROE of +0.39%. Regarding short-term risk, TATACHEM.NS is less volatile compared to MFL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check MFL.NS's competition here
TATACHEM.NS vs CHEMPLASTS.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, CHEMPLASTS.BO has a market cap of 41.8B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while CHEMPLASTS.BO trades at ₹259.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas CHEMPLASTS.BO's P/E ratio is -14.64. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to CHEMPLASTS.BO's ROE of -0.15%. Regarding short-term risk, TATACHEM.NS is less volatile compared to CHEMPLASTS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check CHEMPLASTS.BO's competition here
TATACHEM.NS vs CHEMPLASTS.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, CHEMPLASTS.NS has a market cap of 41.8B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while CHEMPLASTS.NS trades at ₹262.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas CHEMPLASTS.NS's P/E ratio is -14.62. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to CHEMPLASTS.NS's ROE of -0.15%. Regarding short-term risk, TATACHEM.NS is less volatile compared to CHEMPLASTS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check CHEMPLASTS.NS's competition here
TATACHEM.NS vs GUJALKALI.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, GUJALKALI.NS has a market cap of 41.8B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while GUJALKALI.NS trades at ₹587.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas GUJALKALI.NS's P/E ratio is -477.77. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to GUJALKALI.NS's ROE of -0.00%. Regarding short-term risk, TATACHEM.NS is less volatile compared to GUJALKALI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check GUJALKALI.NS's competition here
TATACHEM.NS vs GUJALKALI.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, GUJALKALI.BO has a market cap of 41.7B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while GUJALKALI.BO trades at ₹588.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas GUJALKALI.BO's P/E ratio is -485.77. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to GUJALKALI.BO's ROE of -0.00%. Regarding short-term risk, TATACHEM.NS is less volatile compared to GUJALKALI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check GUJALKALI.BO's competition here
TATACHEM.NS vs GHCL.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, GHCL.NS has a market cap of 38.9B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while GHCL.NS trades at ₹445.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas GHCL.NS's P/E ratio is 7.96. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to GHCL.NS's ROE of +0.15%. Regarding short-term risk, TATACHEM.NS is less volatile compared to GHCL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check GHCL.NS's competition here
TATACHEM.NS vs GHCL.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, GHCL.BO has a market cap of 38.9B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while GHCL.BO trades at ₹445.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas GHCL.BO's P/E ratio is 7.95. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to GHCL.BO's ROE of +0.15%. Regarding short-term risk, TATACHEM.NS is more volatile compared to GHCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check GHCL.BO's competition here
TATACHEM.NS vs RAIN.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, RAIN.BO has a market cap of 35.9B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while RAIN.BO trades at ₹113.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas RAIN.BO's P/E ratio is 84.72. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to RAIN.BO's ROE of +0.01%. Regarding short-term risk, TATACHEM.NS is less volatile compared to RAIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check RAIN.BO's competition here
TATACHEM.NS vs RAIN.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, RAIN.NS has a market cap of 35.8B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while RAIN.NS trades at ₹114.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas RAIN.NS's P/E ratio is 84.52. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to RAIN.NS's ROE of +0.01%. Regarding short-term risk, TATACHEM.NS is less volatile compared to RAIN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check RAIN.NS's competition here
TATACHEM.NS vs MEGH.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, MEGH.NS has a market cap of 35.3B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while MEGH.NS trades at ₹139.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas MEGH.NS's P/E ratio is 15.63. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to MEGH.NS's ROE of +0.16%. Regarding short-term risk, TATACHEM.NS is less volatile compared to MEGH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check MEGH.NS's competition here
TATACHEM.NS vs EPIGRAL.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, EPIGRAL.NS has a market cap of 35B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while EPIGRAL.NS trades at ₹858.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas EPIGRAL.NS's P/E ratio is 10.35. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to EPIGRAL.NS's ROE of +0.18%. Regarding short-term risk, TATACHEM.NS is less volatile compared to EPIGRAL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check EPIGRAL.NS's competition here
TATACHEM.NS vs EPIGRAL.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, EPIGRAL.BO has a market cap of 34.9B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while EPIGRAL.BO trades at ₹859.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas EPIGRAL.BO's P/E ratio is 10.34. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to EPIGRAL.BO's ROE of +0.18%. Regarding short-term risk, TATACHEM.NS is less volatile compared to EPIGRAL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check EPIGRAL.BO's competition here
TATACHEM.NS vs STYRENIX.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, STYRENIX.NS has a market cap of 31.6B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while STYRENIX.NS trades at ₹1,875.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas STYRENIX.NS's P/E ratio is 19.38. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to STYRENIX.NS's ROE of +0.14%. Regarding short-term risk, TATACHEM.NS is less volatile compared to STYRENIX.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check STYRENIX.NS's competition here
TATACHEM.NS vs STYRENIX.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, STYRENIX.BO has a market cap of 31.5B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while STYRENIX.BO trades at ₹1,890.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas STYRENIX.BO's P/E ratio is 19.01. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to STYRENIX.BO's ROE of +0.14%. Regarding short-term risk, TATACHEM.NS is less volatile compared to STYRENIX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check STYRENIX.BO's competition here
TATACHEM.NS vs FOSECOIND.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, FOSECOIND.NS has a market cap of 29.7B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while FOSECOIND.NS trades at ₹4,782.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas FOSECOIND.NS's P/E ratio is 42.12. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to FOSECOIND.NS's ROE of +0.14%. Regarding short-term risk, TATACHEM.NS is less volatile compared to FOSECOIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check FOSECOIND.NS's competition here
TATACHEM.NS vs FOSECOIND.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, FOSECOIND.BO has a market cap of 29.6B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while FOSECOIND.BO trades at ₹4,636.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas FOSECOIND.BO's P/E ratio is 37.38. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to FOSECOIND.BO's ROE of +0.14%. Regarding short-term risk, TATACHEM.NS is less volatile compared to FOSECOIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check FOSECOIND.BO's competition here
TATACHEM.NS vs ELLEN.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, ELLEN.NS has a market cap of 27.8B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while ELLEN.NS trades at ₹206.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas ELLEN.NS's P/E ratio is N/A. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to ELLEN.NS's ROE of +0.09%. Regarding short-term risk, TATACHEM.NS is less volatile compared to ELLEN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check ELLEN.NS's competition here
TATACHEM.NS vs DDEVPLASTIK.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, DDEVPLASTIK.BO has a market cap of 27.2B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while DDEVPLASTIK.BO trades at ₹262.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas DDEVPLASTIK.BO's P/E ratio is 14.39. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to DDEVPLASTIK.BO's ROE of +0.24%. Regarding short-term risk, TATACHEM.NS is less volatile compared to DDEVPLASTIK.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check DDEVPLASTIK.BO's competition here
TATACHEM.NS vs RPEL.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, RPEL.BO has a market cap of 26B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while RPEL.BO trades at ₹609.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas RPEL.BO's P/E ratio is 52.36. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to RPEL.BO's ROE of +0.26%. Regarding short-term risk, TATACHEM.NS is less volatile compared to RPEL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check RPEL.BO's competition here
TATACHEM.NS vs RPEL.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, RPEL.NS has a market cap of 26B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while RPEL.NS trades at ₹613.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas RPEL.NS's P/E ratio is 52.44. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to RPEL.NS's ROE of +0.24%. Regarding short-term risk, TATACHEM.NS is less volatile compared to RPEL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check RPEL.NS's competition here
TATACHEM.NS vs BEPL.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, BEPL.BO has a market cap of 20.5B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while BEPL.BO trades at ₹86.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas BEPL.BO's P/E ratio is 12.31. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to BEPL.BO's ROE of +0.17%. Regarding short-term risk, TATACHEM.NS is less volatile compared to BEPL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check BEPL.BO's competition here
TATACHEM.NS vs BEPL.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, BEPL.NS has a market cap of 20.5B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while BEPL.NS trades at ₹87.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas BEPL.NS's P/E ratio is 12.18. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to BEPL.NS's ROE of +0.17%. Regarding short-term risk, TATACHEM.NS is less volatile compared to BEPL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check BEPL.NS's competition here
TATACHEM.NS vs GODAVARIB.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, GODAVARIB.NS has a market cap of 15.1B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while GODAVARIB.NS trades at ₹313.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas GODAVARIB.NS's P/E ratio is 43.10. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to GODAVARIB.NS's ROE of +0.03%. Regarding short-term risk, TATACHEM.NS is less volatile compared to GODAVARIB.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check GODAVARIB.NS's competition here
TATACHEM.NS vs INEOSSTYRO.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, INEOSSTYRO.NS has a market cap of 14.2B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while INEOSSTYRO.NS trades at ₹807.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas INEOSSTYRO.NS's P/E ratio is 11.53. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to INEOSSTYRO.NS's ROE of +0.23%. Regarding short-term risk, TATACHEM.NS is more volatile compared to INEOSSTYRO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check INEOSSTYRO.NS's competition here
TATACHEM.NS vs SANSTAR.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, SANSTAR.NS has a market cap of 13.8B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while SANSTAR.NS trades at ₹77.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas SANSTAR.NS's P/E ratio is 72.87. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to SANSTAR.NS's ROE of +0.03%. Regarding short-term risk, TATACHEM.NS is less volatile compared to SANSTAR.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check SANSTAR.NS's competition here
TATACHEM.NS vs DCW.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, DCW.BO has a market cap of 11.1B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while DCW.BO trades at ₹40.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas DCW.BO's P/E ratio is 22.22. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to DCW.BO's ROE of +0.04%. Regarding short-term risk, TATACHEM.NS is less volatile compared to DCW.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check DCW.BO's competition here
TATACHEM.NS vs DCW.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, DCW.NS has a market cap of 11.1B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while DCW.NS trades at ₹40.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas DCW.NS's P/E ratio is 26.62. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to DCW.NS's ROE of +0.04%. Regarding short-term risk, TATACHEM.NS is less volatile compared to DCW.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check DCW.NS's competition here
TATACHEM.NS vs PUNJABCHEM.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, PUNJABCHEM.NS has a market cap of 10.9B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while PUNJABCHEM.NS trades at ₹934.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas PUNJABCHEM.NS's P/E ratio is 18.25. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to PUNJABCHEM.NS's ROE of +0.16%. Regarding short-term risk, TATACHEM.NS is less volatile compared to PUNJABCHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check PUNJABCHEM.NS's competition here
TATACHEM.NS vs PUNJABCHEM.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, PUNJABCHEM.BO has a market cap of 10.9B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while PUNJABCHEM.BO trades at ₹928.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas PUNJABCHEM.BO's P/E ratio is 18.10. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to PUNJABCHEM.BO's ROE of +0.16%. Regarding short-term risk, TATACHEM.NS is more volatile compared to PUNJABCHEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check PUNJABCHEM.BO's competition here
TATACHEM.NS vs IGPL.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, IGPL.BO has a market cap of 10.3B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while IGPL.BO trades at ₹354.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas IGPL.BO's P/E ratio is 31.67. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to IGPL.BO's ROE of -0.01%. Regarding short-term risk, TATACHEM.NS is less volatile compared to IGPL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check IGPL.BO's competition here
TATACHEM.NS vs ANDHRSUGAR.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, ANDHRSUGAR.NS has a market cap of 9.7B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while ANDHRSUGAR.NS trades at ₹72.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas ANDHRSUGAR.NS's P/E ratio is 11.60. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to ANDHRSUGAR.NS's ROE of +0.05%. Regarding short-term risk, TATACHEM.NS is more volatile compared to ANDHRSUGAR.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check ANDHRSUGAR.NS's competition here
TATACHEM.NS vs ANDHRSUGAR.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, ANDHRSUGAR.BO has a market cap of 9.7B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while ANDHRSUGAR.BO trades at ₹72.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas ANDHRSUGAR.BO's P/E ratio is 11.60. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to ANDHRSUGAR.BO's ROE of +0.05%. Regarding short-term risk, TATACHEM.NS is more volatile compared to ANDHRSUGAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check ANDHRSUGAR.BO's competition here
TATACHEM.NS vs GULPOLY.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, GULPOLY.NS has a market cap of 9B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while GULPOLY.NS trades at ₹153.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas GULPOLY.NS's P/E ratio is 11.75. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to GULPOLY.NS's ROE of +0.12%. Regarding short-term risk, TATACHEM.NS is less volatile compared to GULPOLY.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check GULPOLY.NS's competition here
TATACHEM.NS vs GULPOLY.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, GULPOLY.BO has a market cap of 8.9B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while GULPOLY.BO trades at ₹153.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas GULPOLY.BO's P/E ratio is 11.67. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to GULPOLY.BO's ROE of +0.12%. Regarding short-term risk, TATACHEM.NS is less volatile compared to GULPOLY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check GULPOLY.BO's competition here
TATACHEM.NS vs ORIENTCQ.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, ORIENTCQ.BO has a market cap of 8.1B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while ORIENTCQ.BO trades at ₹810.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas ORIENTCQ.BO's P/E ratio is 15.88. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to ORIENTCQ.BO's ROE of +0.01%. Regarding short-term risk, TATACHEM.NS is less volatile compared to ORIENTCQ.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check ORIENTCQ.BO's competition here
TATACHEM.NS vs INDOBORAX.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, INDOBORAX.NS has a market cap of 7.8B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while INDOBORAX.NS trades at ₹246.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas INDOBORAX.NS's P/E ratio is 16.95. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to INDOBORAX.NS's ROE of +0.14%. Regarding short-term risk, TATACHEM.NS is more volatile compared to INDOBORAX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check INDOBORAX.NS's competition here
TATACHEM.NS vs INDOBORAX.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, INDOBORAX.BO has a market cap of 7.8B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while INDOBORAX.BO trades at ₹247.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas INDOBORAX.BO's P/E ratio is 16.89. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to INDOBORAX.BO's ROE of +0.14%. Regarding short-term risk, TATACHEM.NS is more volatile compared to INDOBORAX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check INDOBORAX.BO's competition here
TATACHEM.NS vs ZUARI.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, ZUARI.BO has a market cap of 7.7B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while ZUARI.BO trades at ₹193.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas ZUARI.BO's P/E ratio is 0.80. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to ZUARI.BO's ROE of +0.41%. Regarding short-term risk, TATACHEM.NS is less volatile compared to ZUARI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check ZUARI.BO's competition here
TATACHEM.NS vs AMNPLST.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, AMNPLST.BO has a market cap of 7.5B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while AMNPLST.BO trades at ₹135.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas AMNPLST.BO's P/E ratio is 22.04. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to AMNPLST.BO's ROE of +0.13%. Regarding short-term risk, TATACHEM.NS is less volatile compared to AMNPLST.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check AMNPLST.BO's competition here
TATACHEM.NS vs A1L.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, A1L.BO has a market cap of 7.3B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while A1L.BO trades at ₹16.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas A1L.BO's P/E ratio is 198.63. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to A1L.BO's ROE of +0.03%. Regarding short-term risk, TATACHEM.NS is less volatile compared to A1L.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check A1L.BO's competition here
TATACHEM.NS vs GEMAROMA.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, GEMAROMA.NS has a market cap of 7.2B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while GEMAROMA.NS trades at ₹144.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas GEMAROMA.NS's P/E ratio is 25.76. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to GEMAROMA.NS's ROE of +0.08%. Regarding short-term risk, TATACHEM.NS is more volatile compared to GEMAROMA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check GEMAROMA.NS's competition here
TATACHEM.NS vs AMNPLST.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, AMNPLST.NS has a market cap of 7.1B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while AMNPLST.NS trades at ₹136.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas AMNPLST.NS's P/E ratio is 20.85. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to AMNPLST.NS's ROE of +0.13%. Regarding short-term risk, TATACHEM.NS is less volatile compared to AMNPLST.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check AMNPLST.NS's competition here
TATACHEM.NS vs SRHHYPOLTD.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, SRHHYPOLTD.BO has a market cap of 6.6B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while SRHHYPOLTD.BO trades at ₹415.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas SRHHYPOLTD.BO's P/E ratio is 7.07. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to SRHHYPOLTD.BO's ROE of +0.10%. Regarding short-term risk, TATACHEM.NS is less volatile compared to SRHHYPOLTD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check SRHHYPOLTD.BO's competition here
TATACHEM.NS vs SRHHYPOLTD.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, SRHHYPOLTD.NS has a market cap of 6.6B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while SRHHYPOLTD.NS trades at ₹414.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas SRHHYPOLTD.NS's P/E ratio is 7.05. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to SRHHYPOLTD.NS's ROE of +0.10%. Regarding short-term risk, TATACHEM.NS is less volatile compared to SRHHYPOLTD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check SRHHYPOLTD.NS's competition here
TATACHEM.NS vs UNIENTER.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, UNIENTER.NS has a market cap of 6.3B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while UNIENTER.NS trades at ₹95.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas UNIENTER.NS's P/E ratio is 32.00. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to UNIENTER.NS's ROE of +0.01%. Regarding short-term risk, TATACHEM.NS is less volatile compared to UNIENTER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check UNIENTER.NS's competition here
TATACHEM.NS vs INDOAMIN.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, INDOAMIN.NS has a market cap of 6.1B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while INDOAMIN.NS trades at ₹93.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas INDOAMIN.NS's P/E ratio is 8.55. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to INDOAMIN.NS's ROE of +0.22%. Regarding short-term risk, TATACHEM.NS is less volatile compared to INDOAMIN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check INDOAMIN.NS's competition here
TATACHEM.NS vs INDOAMIN.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, INDOAMIN.BO has a market cap of 6.1B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while INDOAMIN.BO trades at ₹93.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas INDOAMIN.BO's P/E ratio is 8.51. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to INDOAMIN.BO's ROE of +0.22%. Regarding short-term risk, TATACHEM.NS is less volatile compared to INDOAMIN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check INDOAMIN.BO's competition here
TATACHEM.NS vs NATPEROX.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, NATPEROX.BO has a market cap of 6B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while NATPEROX.BO trades at ₹1,040.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas NATPEROX.BO's P/E ratio is 399.75. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to NATPEROX.BO's ROE of -0.02%. Regarding short-term risk, TATACHEM.NS is less volatile compared to NATPEROX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check NATPEROX.BO's competition here
TATACHEM.NS vs VALIANTORG.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, VALIANTORG.BO has a market cap of 5.7B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while VALIANTORG.BO trades at ₹223.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas VALIANTORG.BO's P/E ratio is 23.63. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to VALIANTORG.BO's ROE of +0.03%. Regarding short-term risk, TATACHEM.NS is less volatile compared to VALIANTORG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check VALIANTORG.BO's competition here
TATACHEM.NS vs VALIANTORG.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, VALIANTORG.NS has a market cap of 5.7B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while VALIANTORG.NS trades at ₹224.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas VALIANTORG.NS's P/E ratio is 23.58. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to VALIANTORG.NS's ROE of +0.03%. Regarding short-term risk, TATACHEM.NS is less volatile compared to VALIANTORG.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check VALIANTORG.NS's competition here
TATACHEM.NS vs SUNSHIEL.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, SUNSHIEL.BO has a market cap of 5.4B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while SUNSHIEL.BO trades at ₹768.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas SUNSHIEL.BO's P/E ratio is 22.58. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to SUNSHIEL.BO's ROE of +0.25%. Regarding short-term risk, TATACHEM.NS is less volatile compared to SUNSHIEL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check SUNSHIEL.BO's competition here
TATACHEM.NS vs DMCC.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, DMCC.BO has a market cap of 5B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while DMCC.BO trades at ₹210.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas DMCC.BO's P/E ratio is 19.04. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to DMCC.BO's ROE of +0.12%. Regarding short-term risk, TATACHEM.NS is less volatile compared to DMCC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check DMCC.BO's competition here
TATACHEM.NS vs DMCC.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, DMCC.NS has a market cap of 4.9B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while DMCC.NS trades at ₹210.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas DMCC.NS's P/E ratio is 18.87. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to DMCC.NS's ROE of +0.12%. Regarding short-term risk, TATACHEM.NS is less volatile compared to DMCC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check DMCC.NS's competition here
TATACHEM.NS vs PRIMO.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, PRIMO.NS has a market cap of 4.4B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while PRIMO.NS trades at ₹19.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas PRIMO.NS's P/E ratio is 75.13. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to PRIMO.NS's ROE of +0.02%. Regarding short-term risk, TATACHEM.NS is less volatile compared to PRIMO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check PRIMO.NS's competition here
TATACHEM.NS vs ARIES.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, ARIES.BO has a market cap of 4.2B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while ARIES.BO trades at ₹339.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas ARIES.BO's P/E ratio is 9.68. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to ARIES.BO's ROE of +0.15%. Regarding short-term risk, TATACHEM.NS is more volatile compared to ARIES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check ARIES.BO's competition here
TATACHEM.NS vs OCCLLTD.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, OCCLLTD.NS has a market cap of 4B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while OCCLLTD.NS trades at ₹87.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas OCCLLTD.NS's P/E ratio is 10.68. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to OCCLLTD.NS's ROE of +0.09%. Regarding short-term risk, TATACHEM.NS is less volatile compared to OCCLLTD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check OCCLLTD.NS's competition here
TATACHEM.NS vs SHIVALIK.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, SHIVALIK.BO has a market cap of 3.5B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while SHIVALIK.BO trades at ₹239.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas SHIVALIK.BO's P/E ratio is 30.13. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to SHIVALIK.BO's ROE of +0.02%. Regarding short-term risk, TATACHEM.NS is less volatile compared to SHIVALIK.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check SHIVALIK.BO's competition here
TATACHEM.NS vs DCMSRMIND.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, DCMSRMIND.BO has a market cap of 3.1B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while DCMSRMIND.BO trades at ₹175.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas DCMSRMIND.BO's P/E ratio is 3.63. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to DCMSRMIND.BO's ROE of +0.05%. Regarding short-term risk, TATACHEM.NS is less volatile compared to DCMSRMIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check DCMSRMIND.BO's competition here
TATACHEM.NS vs NAPEROL.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, NAPEROL.BO has a market cap of 2.9B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while NAPEROL.BO trades at ₹533.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas NAPEROL.BO's P/E ratio is 30.89. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to NAPEROL.BO's ROE of -0.02%. Regarding short-term risk, TATACHEM.NS is less volatile compared to NAPEROL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check NAPEROL.BO's competition here
TATACHEM.NS vs LORDSCHLO.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, LORDSCHLO.NS has a market cap of 2.7B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while LORDSCHLO.NS trades at ₹115.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas LORDSCHLO.NS's P/E ratio is 10.92. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to LORDSCHLO.NS's ROE of +0.14%. Regarding short-term risk, TATACHEM.NS is less volatile compared to LORDSCHLO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check LORDSCHLO.NS's competition here
TATACHEM.NS vs LORDSCHLO.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, LORDSCHLO.BO has a market cap of 2.7B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while LORDSCHLO.BO trades at ₹113.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas LORDSCHLO.BO's P/E ratio is 10.86. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to LORDSCHLO.BO's ROE of +0.14%. Regarding short-term risk, TATACHEM.NS is less volatile compared to LORDSCHLO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check LORDSCHLO.BO's competition here
TATACHEM.NS vs KANORICHEM.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, KANORICHEM.NS has a market cap of 2.5B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while KANORICHEM.NS trades at ₹60.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas KANORICHEM.NS's P/E ratio is -3.31. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to KANORICHEM.NS's ROE of -0.08%. Regarding short-term risk, TATACHEM.NS is more volatile compared to KANORICHEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check KANORICHEM.NS's competition here
TATACHEM.NS vs KANORICHEM.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, KANORICHEM.BO has a market cap of 2.5B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while KANORICHEM.BO trades at ₹59.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas KANORICHEM.BO's P/E ratio is -3.31. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to KANORICHEM.BO's ROE of -0.08%. Regarding short-term risk, TATACHEM.NS is less volatile compared to KANORICHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check KANORICHEM.BO's competition here
TATACHEM.NS vs OCCL.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, OCCL.NS has a market cap of 2.3B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while OCCL.NS trades at ₹233.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas OCCL.NS's P/E ratio is 77.52. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to OCCL.NS's ROE of +0.02%. Regarding short-term risk, TATACHEM.NS is more volatile compared to OCCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check OCCL.NS's competition here
TATACHEM.NS vs DIAMINESQ.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, DIAMINESQ.NS has a market cap of 2.3B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while DIAMINESQ.NS trades at ₹235.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas DIAMINESQ.NS's P/E ratio is -25.06. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to DIAMINESQ.NS's ROE of -0.06%. Regarding short-term risk, TATACHEM.NS is less volatile compared to DIAMINESQ.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check DIAMINESQ.NS's competition here
TATACHEM.NS vs DIAMINESQ.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, DIAMINESQ.BO has a market cap of 2.3B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while DIAMINESQ.BO trades at ₹237.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas DIAMINESQ.BO's P/E ratio is -25.00. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to DIAMINESQ.BO's ROE of -0.06%. Regarding short-term risk, TATACHEM.NS is more volatile compared to DIAMINESQ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check DIAMINESQ.BO's competition here
TATACHEM.NS vs INDGELA.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, INDGELA.BO has a market cap of 2.1B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while INDGELA.BO trades at ₹315.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas INDGELA.BO's P/E ratio is 8.01. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to INDGELA.BO's ROE of +0.15%. Regarding short-term risk, TATACHEM.NS is less volatile compared to INDGELA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check INDGELA.BO's competition here
TATACHEM.NS vs JAYSYNTH.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, JAYSYNTH.BO has a market cap of 1.3B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while JAYSYNTH.BO trades at ₹10.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas JAYSYNTH.BO's P/E ratio is 10.74. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to JAYSYNTH.BO's ROE of N/A. Regarding short-term risk, TATACHEM.NS is less volatile compared to JAYSYNTH.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check JAYSYNTH.BO's competition here
TATACHEM.NS vs ISHANCH.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, ISHANCH.NS has a market cap of 1.2B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while ISHANCH.NS trades at ₹51.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas ISHANCH.NS's P/E ratio is -10.97. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to ISHANCH.NS's ROE of -0.08%. Regarding short-term risk, TATACHEM.NS is less volatile compared to ISHANCH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check ISHANCH.NS's competition here
TATACHEM.NS vs PAUSHAKLTD.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, PAUSHAKLTD.BO has a market cap of 1.1B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while PAUSHAKLTD.BO trades at ₹381.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas PAUSHAKLTD.BO's P/E ratio is 23.41. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to PAUSHAKLTD.BO's ROE of +0.08%. Regarding short-term risk, TATACHEM.NS is less volatile compared to PAUSHAKLTD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check PAUSHAKLTD.BO's competition here
TATACHEM.NS vs RESGEN.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, RESGEN.BO has a market cap of 1.1B. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while RESGEN.BO trades at ₹54.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas RESGEN.BO's P/E ratio is 12.87. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to RESGEN.BO's ROE of +0.14%. Regarding short-term risk, TATACHEM.NS is less volatile compared to RESGEN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check RESGEN.BO's competition here
TATACHEM.NS vs CHEMCRUX.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, CHEMCRUX.BO has a market cap of 974.4M. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while CHEMCRUX.BO trades at ₹70.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas CHEMCRUX.BO's P/E ratio is 47.00. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to CHEMCRUX.BO's ROE of +0.03%. Regarding short-term risk, TATACHEM.NS is less volatile compared to CHEMCRUX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check CHEMCRUX.BO's competition here
TATACHEM.NS vs POLYCHEM.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, POLYCHEM.BO has a market cap of 791.9M. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while POLYCHEM.BO trades at ₹2,070.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas POLYCHEM.BO's P/E ratio is 4.24. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to POLYCHEM.BO's ROE of +0.40%. Regarding short-term risk, TATACHEM.NS is more volatile compared to POLYCHEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check POLYCHEM.BO's competition here
TATACHEM.NS vs DEEPAKCHEM.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, DEEPAKCHEM.BO has a market cap of 755M. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while DEEPAKCHEM.BO trades at ₹74.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas DEEPAKCHEM.BO's P/E ratio is 6.74. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to DEEPAKCHEM.BO's ROE of +0.19%. Regarding short-term risk, TATACHEM.NS is more volatile compared to DEEPAKCHEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check DEEPAKCHEM.BO's competition here
TATACHEM.NS vs PARAGON.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, PARAGON.NS has a market cap of 696.5M. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while PARAGON.NS trades at ₹39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas PARAGON.NS's P/E ratio is 8.13. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to PARAGON.NS's ROE of N/A. Regarding short-term risk, TATACHEM.NS is less volatile compared to PARAGON.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check PARAGON.NS's competition here
TATACHEM.NS vs ASHOKALC.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, ASHOKALC.BO has a market cap of 551.4M. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while ASHOKALC.BO trades at ₹119.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas ASHOKALC.BO's P/E ratio is -10.04. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to ASHOKALC.BO's ROE of +0.05%. Regarding short-term risk, TATACHEM.NS is less volatile compared to ASHOKALC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TATACHEM.NS.Check ASHOKALC.BO's competition here
TATACHEM.NS vs SANGINITA.NS Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, SANGINITA.NS has a market cap of 485.9M. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while SANGINITA.NS trades at ₹19.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas SANGINITA.NS's P/E ratio is -14.32. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to SANGINITA.NS's ROE of -0.06%. Regarding short-term risk, TATACHEM.NS is more volatile compared to SANGINITA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check SANGINITA.NS's competition here
TATACHEM.NS vs GARODCH.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, GARODCH.BO has a market cap of 482.7M. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while GARODCH.BO trades at ₹138.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas GARODCH.BO's P/E ratio is 76.21. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to GARODCH.BO's ROE of -1.14%. Regarding short-term risk, TATACHEM.NS is more volatile compared to GARODCH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check GARODCH.BO's competition here
TATACHEM.NS vs TRELCHE-B.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, TRELCHE-B.BO has a market cap of 392.2M. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while TRELCHE-B.BO trades at ₹20.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas TRELCHE-B.BO's P/E ratio is N/A. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to TRELCHE-B.BO's ROE of N/A. Regarding short-term risk, TATACHEM.NS is more volatile compared to TRELCHE-B.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check TRELCHE-B.BO's competition here
TATACHEM.NS vs SHIVAAGRO.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, SHIVAAGRO.BO has a market cap of 388.7M. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while SHIVAAGRO.BO trades at ₹39.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas SHIVAAGRO.BO's P/E ratio is 176.82. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to SHIVAAGRO.BO's ROE of +0.00%. Regarding short-term risk, TATACHEM.NS is more volatile compared to SHIVAAGRO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check SHIVAAGRO.BO's competition here
TATACHEM.NS vs ZR2.BO Comparison April 2026
TATACHEM.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TATACHEM.NS stands at 148.6B. In comparison, ZR2.BO has a market cap of 351.4M. Regarding current trading prices, TATACHEM.NS is priced at ₹609.10, while ZR2.BO trades at ₹103.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TATACHEM.NS currently has a P/E ratio of 91.71, whereas ZR2.BO's P/E ratio is 364.63. In terms of profitability, TATACHEM.NS's ROE is +0.01%, compared to ZR2.BO's ROE of +0.01%. Regarding short-term risk, TATACHEM.NS is more volatile compared to ZR2.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TATACHEM.NS.Check ZR2.BO's competition here